androstenediol has been researched along with Fibrocystic Breast Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hackenberg, R; Schulz, KD | 1 |
| Adeline, J; Bournique, B; Nahoul, K; Scholler, R | 2 |
1 review(s) available for androstenediol and Fibrocystic Breast Disease
| Article | Year |
|---|---|
Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen- and androgen-like steroids.
Topics: Androgen Antagonists; Androgens; Androstane-3,17-diol; Androstenediol; Antineoplastic Agents, Hormonal; Apolipoproteins; Apolipoproteins D; Breast Neoplasms; Carcinoma; Carrier Proteins; Endometrial Neoplasms; Estrogen Antagonists; Female; Fibrocystic Breast Disease; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Medroxyprogesterone Acetate; Membrane Transport Proteins; Neoplasm Proteins; Pleural Effusion; Receptors, Androgen; Tumor Cells, Cultured | 1996 |
2 other study(ies) available for androstenediol and Fibrocystic Breast Disease
| Article | Year |
|---|---|
[Radioimmunoassay of 5-androstene-3 beta, 17 beta-diol in plasma and breast cyst fluid].
Topics: Adult; Androstenediol; Androstenediols; Female; Fibrocystic Breast Disease; Humans; Male; Middle Aged; Radioimmunoassay; Reference Values | 1986 |
Radioimmunoassay of 5-androstene-3 beta,17 beta-diol in plasma and in breast cyst fluid.
Topics: Androstenediol; Androstenediols; Female; Fibrocystic Breast Disease; Humans; Immune Sera; Radioimmunoassay; Testosterone | 1986 |